Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Market Size

  • Report ID: GMI9862
  • Published Date: Jun 2024
  • Report Format: PDF

Hyperhidrosis Treatment Market Size

Hyperhidrosis Treatment Market size in 2023 was valued at USD 671.6 million and is predicted to showcase growth at 5.3% CAGR from 2024 and 2032. One of the primary factors driving the growth of the market is the rising awareness and diagnosis of the condition.

 

Traditionally, hyperhidrosis was underdiagnosed and undertreated due to a lack of awareness among patients and healthcare providers. However, increasing public health campaigns and educational initiatives are now highlighting the impact of excessive sweating on quality of life, leading more individuals to seek medical advice and treatment.

 

Furthermore, significant advancements in medical technology are fueling the growth of the hyperhidrosis treatment market. Innovative treatments, such as microwave thermolysis (e.g., MiraDry), laser therapies, and iontophoresis devices, offer effective and less invasive options for managing hyperhidrosis. Additionally, the development of novel botulinum toxin formulations and delivery systems has improved the efficacy and duration of injectable treatments. These technological advancements provide patients with more choices and better outcomes, thus driving market expansion.

 

Hyperhidrosis is a medical condition characterized by excessive sweating beyond what is necessary for thermoregulation. It can be either localized (affecting specific areas like the palms, soles, underarms, or face) or generalized (affecting the entire body). It can significantly impact the quality of life, leading to social, emotional, and occupational challenges. The choice of treatment depends on the severity of the condition, the areas affected, and the patient's response to initial therapies.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global hyperhidrosis treatment industry was valued at USD 671.6 million in 2023 and is anticipated to register 5.3% CAGR between 2024 and 2032 due to the increasing prevalence of hyperhidrosis and growing awareness and diagnosis rates.

The axillary segment in the market held 44.8% revenue share in 2023 due to high prevalence of axillary hyperhidrosis and wide range of effective treatment options that are readily available and widely accepted by both patients and healthcare providers.

North America hyperhidrosis treatment market size is expected to record 5% CAGR between 2024 and 2032 due to the presence of advanced healthcare infrastructure, technological advancements and ongoing research initiatives.

AbbVie Inc., Avanor Healthcare Ltd., Brickell Biotech Inc., Dermadry Laboratories Inc., Dermavant Sciences Inc., Hugel, Inc., Eirion Therapeutics, Inc, Eli Lilly and Company, Intas Pharmaceuticals Ltd and Kaken Pharmaceutical Co., Ltd., among others.

Hyperhidrosis Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 331
  • Countries covered: 22
  • Pages: 189
 Download Free Sample